Anti-rubella IgG serum levels predict risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections

Moritz M Hollstein¹, Sascha Dierks^{2

3}, Michael P Schön^{1

4}, Uwe Groß^{3

5}, Karin Thiele^{2

3}, Andreas Leha⁶, Andreas E Zautner^{5

7

8}, Andreas Fischer^{2

3}, Luise Erpenbeck^{1

9}, Moritz Schnelle^{2

3}

Affiliations

¹ Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
² Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.
³ Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.
⁴ Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany.
⁵ Institute of Medical Microbiology and Virology, University Medical Center Göttingen, Göttingen, Germany.
⁶ Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
⁷ Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
⁸ Center for Health and Medical Prevention (CHaMP), Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
⁹ Department of Dermatology, University of Münster, Münster, Germany.

Moritz M Hollstein et al. Allergy. 2024 Nov.

. 2024 Nov;79(11):3154-3156.

doi: 10.1111/all.16232. Epub 2024 Jul 9.

¹ Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
² Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.
³ Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.
⁴ Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany.
⁵ Institute of Medical Microbiology and Virology, University Medical Center Göttingen, Göttingen, Germany.
⁶ Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
⁷ Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
⁸ Center for Health and Medical Prevention (CHaMP), Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
⁹ Department of Dermatology, University of Münster, Münster, Germany.

No abstract available

References

1. Accorsi EK, Britton A, Fleming‐Dutra KE, et al. Association between 3 doses of mRNA COVID‐19 vaccine and symptomatic infection caused by the SARS‐CoV‐2 omicron and delta variants. JAMA. 2022;327(7):639‐651. doi:10.1001/jama.2022.0470
1. Lipsitch M, Krammer F, Regev‐Yochay G, Lustig Y, Balicer RD. SARS‐CoV‐2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat Rev Immunol. 2022;22(1):57‐65. doi:10.1038/s41577-021-00662-4
1. Liu Y, Liu P, Sun Y, Deng G. Clinical characteristics, outcomes, and risk factors of SARS‐CoV‐2 breakthrough infections among 572 fully vaccinated (BBIBP‐CorV) hospitalized patients. Heliyon. 2023;9(11):e21387. doi:10.1016/j.heliyon.2023.e21387
1. Hollstein MM, Dierks S, Schön MP, et al. Humoral and cellular immune responses in fully vaccinated individuals with or without SARS‐CoV‐2 breakthrough infection: results from the CoV‐ADAPT cohort. J Med Virol. 2023;95(10):e29122. doi:10.1002/jmv.29122
1. Nakaharai K, Nakazawa Y, Mishima Y, Saito M, Shinozaki Y, Yoshida M. Association between a low response to rubella vaccination and reduced anti‐severe acute respiratory syndrome coronavirus 2 immune response after vaccination with BNT162b2: a cross‐sectional study. Clin Microbiol Infect. 2023;29(2):253.e1‐253.e5. doi:10.1016/j.cmi.2022.09.007